Lack of Sterility Assurance: The product has the potential to leak at the administrative port.
Take action
Contact the company
📍Recalling firmHospira Inc.600 N Field Dr · Lake Forest, IL 60045-4835
✎ GovInfoNow plain-language explainer
Hospira Inc. is recalling 0.9% Sodium Chloride Injection, USP, in 100 mL ADD-Vantage flexible containers because the product has the potential to leak at the administrative port. This defect creates a lack of sterility assurance for the medication. The recall affects units distributed nationwide. Read more at govinfonow.com/recall/44812-hospira-inc-recalls-0-9-sodium-chloride-injection-usp-100.
“Hospira Recalls Sodium Chloride Injection Due to Leak Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44812-hospira-inc-recalls-0-9-sodium-chloride-injection-usp-100. Based on FDA recall #D-0490-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0490-2015%22&limit=1).
Hospira Inc. voluntarily recalled 0.9% Sodium Chloride Injection, USP, 100 mL ADD-Vantage Units on April 7, 2015, due to a potential leak at the administrative port that compromises sterility assurance, according to the FDA. The recall affects 128,050 units distributed nationwide.
How to tell if you have it
Brand: Hospira
Product: 0.9% Sodium Chloride Injection, USP, 100 mL ADD-Vantage Unit
NDC: 0409-7101-67
Lot#: 44-110-JT
Expiration: 08/16
The hazard
The product has the potential to leak at the administrative port, creating a lack of sterility assurance. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Fresenius Kabi 1000mL Sodium Chloride Injection Recall (March 11, 2026), Huons Co. 10mL Sodium Chloride Injection Recall (April 2, 2026), and Fresenius Kabi 500mL Sodium Chloride Injection Recall (March 11, 2026).
How to tell if you have this one
Check if you have 0.9% Sodium Chloride Injection, USP, 100 mL ADD-Vantage Units manufactured by Hospira Inc. Look for NDC: 0409-7101-67 and Lot# 44-110-JT with an expiration date of 08/16.
Brand
Hospira
Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0490-2015 (April 7, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0490-2015 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.